The Kessler Foundation and the New Jersey Institute of Technology (NJIT) will share a $5 million federal grant, titled Rehabilitation…
Magdalena Kegel
Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Magdalena Kegel
Advances in stem cell therapy using patients’ own cells with genetically modified dystrophin have been hampered by the large size of…
Akashi Therapeutics announced they are suspending both dosing and patient enrollment in the HALO trial – a study investigating their…
Duke University researcher Brent Hoffman is investigating the mechanical nature of major diseases — a research area named mechanobiology —…
Researchers have found that RNA sequencing is able to identify disease-causing genetic mutations in non-coding regions of the DNA. The technique can…
Researchers from Duke University have succeeded in treating an adult mouse model of Duchenne muscular dystrophy using the gene editing system…